142 related articles for article (PubMed ID: 10818595)
1. p53 and APC mutations are detectable in the plasma and serum of patients with colorectal cancer (CRC) or adenomas.
Gocke CD; Benko FA; Kopreski MS; McGarrity TJ
Ann N Y Acad Sci; 2000 Apr; 906():44-50. PubMed ID: 10818595
[TBL] [Abstract][Full Text] [Related]
2. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.
Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR
World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002
[TBL] [Abstract][Full Text] [Related]
4. Association between cigarette smoking, APC mutations and the risk of developing sporadic colorectal adenomas and carcinomas.
Sarebø M; Skjelbred CF; Breistein R; Lothe IM; Hagen PC; Bock G; Hansteen IL; Kure EH
BMC Cancer; 2006 Mar; 6():71. PubMed ID: 16545110
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas.
van Wyk R; Slezak P; Hayes VM; Buys CH; Kotze MJ; de Jong G; Rubio C; Dolk A; Jaramillo E; Koizumi K; Grobbelaar JJ
Genes Chromosomes Cancer; 2000 Feb; 27(2):202-8. PubMed ID: 10612810
[TBL] [Abstract][Full Text] [Related]
6. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer.
Lauschke H; Caspari R; Friedl W; Schwarz B; Mathiak M; Propping P; Hirner A
Cancer Detect Prev; 2001; 25(1):55-61. PubMed ID: 11270422
[TBL] [Abstract][Full Text] [Related]
7. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
8. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients.
Jeon CH; Lee HI; Shin IH; Park JW
Int J Colorectal Dis; 2008 Jan; 23(1):29-35. PubMed ID: 17704924
[TBL] [Abstract][Full Text] [Related]
10. The differentially mutational spectra of the APC, K-ras, and p53 genes in sporadic colorectal cancers from Taiwanese patients.
Wang JY; Hsieh JS; Lu CY; Yu FJ; Wu JY; Chen FM; Huang CJ; Lin SR
Hepatogastroenterology; 2007 Dec; 54(80):2259-65. PubMed ID: 18265644
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal instability and APC gene mutations in human sporadic colorectal adenomas.
Giaretti W; Venesio T; Prevosto C; Lombardo F; Ceccarelli J; Molinu S; Risio M
J Pathol; 2004 Oct; 204(2):193-9. PubMed ID: 15376262
[TBL] [Abstract][Full Text] [Related]
12. The effect of dietary folate on Apc and p53 mutations in the dimethylhydrazine rat model of colorectal cancer.
Sohn KJ; Puchyr M; Salomon RN; Graeme-Cook F; Fung L; Choi SW; Mason JB; Medline A; Kim YI
Carcinogenesis; 1999 Dec; 20(12):2345-50. PubMed ID: 10590231
[TBL] [Abstract][Full Text] [Related]
13. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP).
Ichii S; Takeda S; Horii A; Nakatsuru S; Miyoshi Y; Emi M; Fujiwara Y; Koyama K; Furuyama J; Utsunomiya J
Oncogene; 1993 Sep; 8(9):2399-405. PubMed ID: 8395678
[TBL] [Abstract][Full Text] [Related]
14. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
Kim H; Yang XL; Rosada C; Hamilton SR; August JT
Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
[TBL] [Abstract][Full Text] [Related]
15. APC mutations in human colorectal adenomas: analysis of the mutation cluster region with temperature gradient gel electrophoresis and clinicopathological features.
Mulkens J; Poncin J; Arends JW; De Goeij AF
J Pathol; 1998 Aug; 185(4):360-5. PubMed ID: 9828834
[TBL] [Abstract][Full Text] [Related]
16. Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas.
Rashid A; Zahurak M; Goodman SN; Hamilton SR
Gut; 1999 Jun; 44(6):826-33. PubMed ID: 10323885
[TBL] [Abstract][Full Text] [Related]
17. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.
Clarke AR; Cummings MC; Harrison DJ
Oncogene; 1995 Nov; 11(9):1913-20. PubMed ID: 7478622
[TBL] [Abstract][Full Text] [Related]
18. APC and p53 mutations in de novo colorectal adenocarcinomas.
Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y
Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386
[TBL] [Abstract][Full Text] [Related]
19. Further evidence that one of the earliest alterations in colorectal carcinogenesis involves APC.
Tsao J; Shibata D
Am J Pathol; 1994 Sep; 145(3):531-4. PubMed ID: 8080037
[TBL] [Abstract][Full Text] [Related]
20. APC and K-ras gene mutation in aberrant crypt foci of human colon.
Yuan P; Sun MH; Zhang JS; Zhu XZ; Shi DR
World J Gastroenterol; 2001 Jun; 7(3):352-6. PubMed ID: 11819789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
